REVELATION BIOSCIENCES, INC. (REVBW) Operating income 2021–2025
REVELATION BIOSCIENCES, INC. (REVBW) annual operating income history from SEC filings — each fiscal year as reported.
-$9.1MFY2025 · since FY2021: -$12.0M → -$9.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.1M | -13.7% |
| FY2024 | -$8.0M | +7.9% |
| FY2023 | -$8.7M | +20.3% |
| FY2022 | -$10.9M | +9.1% |
| FY2021 | -$12.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More REVBW financial trends
REVBW RevenueREVBW Net incomeREVBW Net marginREVBW Gross profitREVBW Gross marginREVBW Operating marginREVBW Operating cash flowREVBW Free cash flowREVBW Capital expendituresREVBW Return on equityREVBW Stock buybacksREVBW Dividends paidREVBW Total assetsREVBW Total liabilitiesREVBW Shareholders’ equityREVBW overview →